A Kochi1, B Vareldzis, K Styblo. Show Affiliations » 1. World Health Organization Tuberculosis Programme, Geneva, Switzerland.
Abstract
Entities: Disease
Mesh: See more » AIDS-Related Opportunistic Infections/complicationsAIDS-Related Opportunistic Infections/drug therapyAntibiotics, Antitubercular/therapeutic useDrug Resistance, MicrobialDrug Therapy, CombinationHIV Infections/complicationsHumansIsoniazid/therapeutic useRifampin/therapeutic useStreptomycin/therapeutic useTuberculosis/complicationsTuberculosis/drug therapyTuberculosis, Pulmonary/complicationsTuberculosis, Pulmonary/drug therapy
Substances: See more » Antibiotics, AntitubercularIsoniazidRifampinStreptomycin
Year: 1993 PMID: 8337467 DOI: 10.1016/0923-2508(93)90023-u
Source DB: PubMed Journal: Res Microbiol ISSN: 0923-2508 Impact factor: 3.992